Bernard Mach
Oprichter bij MaxiVAX SA
Actieve functies van Bernard Mach
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Directeur/Bestuurslid | 01-01-2005 | - |
Oprichter | 01-01-2005 | - |
Loopbaan van Bernard Mach
Eerdere bekende functies van Bernard Mach
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LO FUNDS LIFE SCIENCES EXPERTISE | Oprichter | - | 28-03-2014 |
Corporate Officer/Principal | - | - | |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Directeur/Bestuurslid | 01-01-1997 | 17-01-2007 |
University of Geneva | Corporate Officer/Principal | - | 01-01-1998 |
NOVIMMUNE SA | Directeur/Bestuurslid | 27-04-2010 | - |
Oprichter | 27-04-2010 | - | |
LONZA GROUP AG | Directeur/Bestuurslid | - | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - | - |
Oprichter | - | - |
Opleiding van Bernard Mach
The Rockefeller University | Doctorate Degree |
University of Geneva | Doctorate Degree |
Statistieken
Internationaal
Zwitserland | 7 |
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 5 |
Founder | 4 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LONZA GROUP AG | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
LO FUNDS LIFE SCIENCES EXPERTISE | Miscellaneous |
Novimmune SA
Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Commercial Services |
- Beurs
- Insiders
- Bernard Mach
- Ervaring